Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
reports
Cyclacel Pharmaceuticals (CYCC) Stock Price & Analysis
570 Followers
CYCC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.50 - $2.41
Previous Close$0.68
Volume20.10K
Average Volume (3M)52.03K
Market Cap
$8.53M
Enterprise Value$1.66M
Total Cash (Recent Filing)$11.44M
Total Debt (Recent Filing)$80.00K
Price to Earnings (P/E)-0.3
Beta1.35
Next Earnings
Aug 09, 2023EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.94
Shares Outstanding12,539,189
10 Day Avg. Volume28,240
30 Day Avg. Volume52,034
Standard Deviation0.24
R-Squared0.06
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)1.67
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.06
Forecast
1Y Price Target
$8.00Price Target Upside1093.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cyclacel Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CYCC FAQ
What was Cyclacel Pharmaceuticals’s price range in the past 12 months?
Cyclacel Pharmaceuticals lowest stock price was $0.50 and its highest was $2.41 in the past 12 months.
What is Cyclacel Pharmaceuticals’s market cap?
Currently, no data Available
When is Cyclacel Pharmaceuticals’s upcoming earnings report date?
Cyclacel Pharmaceuticals’s upcoming earnings report date is Aug 09, 2023 which is in 60 days.
How were Cyclacel Pharmaceuticals’s earnings last quarter?
Cyclacel Pharmaceuticals released its earnings results on May 11, 2023. The company reported -$0.47 earnings per share for the quarter, beating the consensus estimate of -$0.663 by $0.193.
Is Cyclacel Pharmaceuticals overvalued?
According to Wall Street analysts Cyclacel Pharmaceuticals’s price is currently Undervalued.
Does Cyclacel Pharmaceuticals pay dividends?
Cyclacel Pharmaceuticals does not currently pay dividends.
What is Cyclacel Pharmaceuticals’s EPS estimate?
Cyclacel Pharmaceuticals’s EPS estimate is -$0.53.
How many shares outstanding does Cyclacel Pharmaceuticals have?
Cyclacel Pharmaceuticals has 12,539,189 shares outstanding.
What happened to Cyclacel Pharmaceuticals’s price movement after its last earnings report?
Cyclacel Pharmaceuticals reported an EPS of -$0.47 in its last earnings report, beating expectations of -$0.663. Following the earnings report the stock price went down -1.786%.
Which hedge fund is a major shareholder of Cyclacel Pharmaceuticals?
Currently, no hedge funds are holding shares in CYCC
---
Cyclacel Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (1093.41% Upside)
$8.00 (1093.41% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.53%
12-Months-Change
Fundamentals
Return on Equity
-95.29%
Trailing 12-Months
Asset Growth
-44.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
---
Top 5 ETFs holding CYCC
iShares Core S&P Total U.S. Stock Market ETF
$2.85K
Up to five ETFs with an Outperform Smart Score that hold CYCC. The ETFs are listed according to market value of CYCC within the ETF
---
---